Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORTE Trial in Newly Diagnosed Multiple Myeloma
NCT02203643Phase 2Completed
- Start
- Feb 2015
- Primary completion
- Oct 2016
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM). Started Feb 2015; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02203643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203643.